Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
NYSE:VRX
Tag: NYSE:VRX
Analyst Upgrades – NYSE:VRX – Valeant Pharmaceuticals International (NYSE:VRX) Stock Gets...
ME Staff
-
May 15, 2018
0
Analyst Upgrades – NYSE:VRX – Valeant Pharmaceuticals International (NYSE:VRX) Stock Gets...
ME Staff
-
May 15, 2018
0
Valeant Pharmaceuticals International (NYSE:VRX) reported earnings of $0.89 per share beating...
ME Staff
-
May 8, 2018
0
Analyst Upgrades – VRX – Valeant Pharmaceuticals International (NYSE:VRX) Stock Gets...
ME Staff
-
April 6, 2018
0
Valeant Pharmaceuticals Intl (NYSE:VRX) reported earnings of $0.98 per share beating...
ME Staff
-
February 28, 2018
0
Here’s What’s Moving Pieris Pharmaceuticals And Valeant Pharmaceuticals
ME Contributor
-
February 12, 2018
0
Biotech Movers: Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Aerie Pharmaceuticals Inc (NASDAQ:AERI)...
ME Contributor
-
August 17, 2017
0
Analyst Activity – BMO Capital Markets Reiterates Hold on Valeant Pharmaceuticals...
ME Staff
-
July 27, 2017
0
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Unveils Glumetza Generic in US
ME Contributor
-
May 16, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) Agree To $50...
ME Contributor
-
December 20, 2016
0
1
2
3
Page 1 of 3
/* */
// AST – IMS - [MarketExclusive_ROS]